We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Use of Molecular Assays for HIAs Growing Rapidly

By LabMedica International staff writers
Posted on 07 Oct 2010
Molecular tests that can quickly identify hospital- acquired infections (HIAs) are rapidly becoming more popular. More...


The most serious HAIs include methicillin resistant Staphylococcus aureus (MRSA), Clostridium difficile, which causes an intestinal infection), Vancomycin-resistant Enterococcus, linked with intestinal, skin and blood infections, and drug-resistant Acinetobacter, which can cause pneumonia, skin, and blood infections.

There are several approaches to HAI detection. On the conservative and least expensive side are chromogenic growth media that permit the selective growth of MRSA bacteria and produce a colored colony that is easily recognizable. On the more expensive side, there has been an explosion of user-friendly molecular assays that are widely accepted.

Kalorama Information (Rockville, MD, USA), a healthcare market research publisher, has reported that molecular tests that can quickly identify patients for isolation and treatment are being utilized despite their higher cost. Kalorama forecasts that revenues for molecular tests that detect HAIs will grow at 25% per year for the next five years.

"They are growing at four times the rate of the average IVD products,” said Shara Rosen, senior diagnostic analyst for Kalorama Information and the author of the report. "HAIs are a huge problem and this is an opportunity for the most logical tests to treat them.”

The advantage of these molecular tests is that they can provide highly sensitive rapid turnaround results. Cepheid (Sunnyvale, CA, USA), Becton Dickinson (BD; Franklin Lakes, CA, USA), and Seegene (Seoul, Korea) are among the companies with products used to test for HAIs.

The US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) estimates that HAIs affect nearly 2 million Americans annually, resulting in 90,000 deaths and up to US $6.5 billion in extra costs.

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services.

Related Links:
Cepheid
Becton Dickinson
Seegene
Kalorama Information
U.S. Centers for Disease Control and Prevention



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.